dc.contributor.author |
Spencer Clinton, Jennifer L.
|
|
dc.contributor.author |
Hoornweg, Tabitha E.
|
|
dc.contributor.author |
Tan, Jie
|
|
dc.contributor.author |
Peng, Rongsheng
|
|
dc.contributor.author |
Schaftenaar, Willem
|
|
dc.contributor.author |
Rutten, Victor P.M.G.
|
|
dc.contributor.author |
De Haan, Cornelis A.M.
|
|
dc.contributor.author |
Ling, Paul D.
|
|
dc.date.accessioned |
2025-03-20T10:16:23Z |
|
dc.date.issued |
2024-10 |
|
dc.description |
DATA AVAILABILITY : Data will be made available on request. |
en_US |
dc.description.abstract |
Elephant endotheliotropic herpesvirus (EEHV) causes lethal hemorrhagic disease (HD) in Asian and African elephants. Although rapid detection of viremia and supportive treatments may improve survival rates, an effective vaccine would mitigate the devastating effects of this virus. In elephants, chronic infection with EEHV leads to adaptive immunity against glycoproteins gB and gH/gL, the core entry machinery for most herpesviruses. We previously evaluated two EEHV gB vaccines in mice but not a gH/gL vaccine. Here, we found that inoculation of mice with an adjuvanted EEHV gH/gL subunit vaccine induced a significant antibody response that was similar to the response observed in elephants chronically infected with EEHV. Moreover, the gH/gL heterodimer elicited polyfunctional T cells with a Th1 phenotype but no detectable Th2 response. These results suggest that gH/gL, possibly in combination with gB, may be suitable immunogens for a vaccine comprising herpesvirus glycoproteins that are known to mediate cell entry and infection. |
en_US |
dc.description.department |
Veterinary Tropical Diseases |
en_US |
dc.description.embargo |
2025-08-23 |
|
dc.description.librarian |
hj2024 |
en_US |
dc.description.sdg |
SDG-03:Good heatlh and well-being |
en_US |
dc.description.sponsorship |
The International Elephant Foundation (IEF); Houston Zoo; Named Fund Friends of VetMed to the Utrecht University EEHV research group and NIH training grant. |
en_US |
dc.description.uri |
https://www.elsevier.com/locate/vaccine |
en_US |
dc.identifier.citation |
Spencer Clinton, J.L., Hoornweg, T.E., Tan, J. et al. 2024, 'The EEHV1A gH/gL complex elicits humoral and cell-mediated immune responses in mice', Vaccine, vol. 42, no. 23, art. 126227, pp. 1-10, doi : 10.1016/j.vaccine.2024.126227. |
en_US |
dc.identifier.issn |
0264-410X (print) |
|
dc.identifier.issn |
1873-2518 (online) |
|
dc.identifier.other |
10.1016/j.vaccine.2024.126227 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/101626 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Elsevier |
en_US |
dc.rights |
© 2024 Published by Elsevier Ltd. Notice : this is the author’s version of a work that was accepted for publication in Vaccine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Vaccine, vol. 42, no. 23, art. 126227, pp. 1-10, doi : 10.1016/j.vaccine.2024.126227. |
en_US |
dc.subject |
Elephant endotheliotropic herpesvirus (EEHV) |
en_US |
dc.subject |
Herpesvirus |
en_US |
dc.subject |
Vaccines |
en_US |
dc.subject |
Elephants (Loxodonta africana) |
en_US |
dc.subject |
SDG-03: Good health and well-being |
en_US |
dc.title |
The EEHV1A gH/gL complex elicits humoral and cell-mediated immune responses in mice |
en_US |
dc.type |
Postprint Article |
en_US |